Trinity Biotech - 23 Year Stock Price History | TRIB

Historical daily share price chart and data for Trinity Biotech since 1995 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Trinity Biotech as of October 22, 2018 is 2.91.
Trinity Biotech Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 4.7829 5.1800 6.0600 2.9100 2.9100 -42.94%
2017 5.6609 6.9600 7.0400 4.5000 5.1000 -26.30%
2016 10.3162 11.6800 13.5300 6.3100 6.9200 -41.16%
2015 15.7967 17.9300 19.8070 10.8300 11.7600 -32.01%
2014 21.7848 24.3824 27.2797 15.8555 17.2978 -29.71%
2013 18.6682 14.2047 25.0871 14.1079 24.6075 76.36%
2012 11.6524 9.6455 14.9014 9.3972 13.9531 43.52%
2011 9.2239 8.0932 10.3426 7.8474 9.7219 16.72%
2010 5.8114 3.7606 8.4147 3.6306 8.3296 118.07%
2009 3.0323 1.5506 4.6801 0.9927 3.8197 152.51%
2008 3.5104 6.2306 6.5710 1.1818 1.5127 -76.51%
2007 9.3563 8.3107 11.1093 5.4081 6.4387 -20.54%
2006 8.1028 7.7623 9.0198 6.7034 8.1027 5.03%
2005 7.7621 11.0809 11.0809 5.9375 7.7150 -31.08%
2004 12.3019 20.0817 20.0817 9.5681 11.1943 -46.95%
2003 10.4951 5.4837 23.4060 4.7273 21.1028 313.33%
2002 5.0907 5.6728 6.9586 3.5171 5.1055 -11.18%
2001 7.2352 8.5092 11.3456 4.3113 5.7484 -32.44%
2000 12.6798 6.6183 28.1371 6.6183 8.5092 33.14%
1999 6.4642 5.5594 8.5092 4.3870 6.3914 29.01%
1998 6.8703 7.7907 9.6816 3.5550 4.9543 -33.50%
1997 9.5882 8.7361 11.9507 6.1645 7.4503 -15.81%
1996 14.0297 13.6904 24.1283 8.5092 8.8496 -39.69%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.061B $0.099B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.435B 19.38
Abbott Laboratories (ABT) United States $120.206B 24.38
Stryker (SYK) United States $62.741B 24.24
Boston Scientific (BSX) United States $50.643B 26.34
Baxter (BAX) United States $36.875B 25.10
Zimmer Biomet Holdings (ZBH) United States $25.257B 16.23
ResMed (RMD) United States $14.644B 29.07
Smith & Nephew SNATS (SNN) United Kingdom $14.612B 0.00
Perrigo (PRGO) Ireland $9.748B 13.83
Canopy Growth (CGC) Canada $9.572B 0.00
Bio-Rad Laboratories (BIO) United States $8.308B 53.35
Hill-Rom Holdings (HRC) United States $5.726B 19.42
Haemonetics (HAE) United States $5.555B 50.69
ICU Medical (ICUI) United States $5.444B 36.89
Insulet (PODD) United States $5.198B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.212B 0.00
Hutchison China MediTech (HCM) China $3.983B 0.00
Agios Pharmaceuticals (AGIO) United States $3.643B 0.00
Neogen (NEOG) United States $3.276B 49.61
NuVasive (NUVA) United States $3.270B 31.02
National Vision Holdings (EYE) United States $3.195B 70.55
Quidel (QDEL) United States $2.516B 51.55
NxStage Medical (NXTM) United States $1.836B 0.00
Phibro Animal Health (PAHC) United States $1.796B 25.58
Cardiovascular Systems (CSII) United States $1.258B 724.80
AtriCure (ATRC) United States $1.059B 0.00
VAREX IMAGING (VREX) United States $0.987B 16.12
Owens & Minor (OMI) United States $0.914B 9.77
OraSure Technologies (OSUR) United States $0.909B 59.44
Cerus (CERS) United States $0.879B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.875B 25.83
PetIQ (PETQ) United States $0.860B 28.12
Surmodics (SRDX) United States $0.853B 103.08
MacroGenics (MGNX) United States $0.766B 0.00
Omeros (OMER) United States $0.749B 0.00
Meridian Bioscience (VIVO) United States $0.661B 22.59
Insys Therapeutics (INSY) United States $0.607B 0.00
LeMaitre Vascular (LMAT) United States $0.542B 26.98
Lantheus Holdings (LNTH) United States $0.510B 15.85
NanoString Technologies (NSTG) United States $0.452B 0.00
TG Therapeutics (TGTX) United States $0.423B 0.00
Quanterix (QTRX) United States $0.405B 0.00
Evolus (EOLS) United States $0.359B 0.00
Cytosorbents (CTSO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.322B 20.76
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.295B 0.00
Surface Oncology (SURF) United States $0.230B 0.00
Rockwell Medical (RMTI) United States $0.221B 0.00
BioLife Solutions (BLFS) United States $0.209B 0.00
Chimerix (CMRX) United States $0.170B 0.00
Bovie Medical (BVX) United States $0.168B 0.00
Fonar (FONR) United States $0.146B 7.21
Chembio Diagnostics (CEMI) United States $0.140B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.136B 0.00
United-Guardian (UG) United States $0.079B 17.33
Imprimis Pharmaceuticals (IMMY) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.073B 0.00
Female Health (VERU) United States $0.073B 0.00
InfuSystems Holdings (INFU) United States $0.062B 0.00
Neurotrope (NTRP) United States $0.055B 0.00
CAS Medical Systems (CASM) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Akers Biosciences Inc (AKER) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Capricor Therapeutics (CAPR) United States $0.026B 0.00
Myomo (MYO) United States $0.022B 0.00
Senestech (SNES) United States $0.022B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00